Large vessel cerebral atherosclerosis is not in direct association with neuropathological lesions of alzheimer's disease

European Neurology

Volumn 62, Issue 2, 2009, Pages 93-98

  Luoto, Teemu M ^a   Haikonen, Satu ^a   Haapasalo, Hannu ^b   Goebeler, Sirkka ^a   Huhtala, Heini ^c   Erkinjuntti, Timo ^d   Karhunen, Pekka J ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Amyloid plaque; Atherosclerosis; Autopsy; Circle of Willis; Neurofibrillary tangle

Indexed keywords

AMYLOID; APOLIPOPROTEIN E4;

AGE DISTRIBUTION; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROTIC PLAQUE; AUTOPSY; BRAIN ATHEROSCLEROSIS; BRAIN CIRCULUS ARTERIOSUS; BRAIN DAMAGE; DISEASE ASSOCIATION; FRONTAL CORTEX; GREAT BLOOD VESSEL; HIPPOCAMPUS; HUMAN; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CHILD; CHILD, PRESCHOOL; CIRCLE OF WILLIS; FEMALE; HIPPOCAMPUS; HUMANS; INFANT; INFANT, NEWBORN; INTRACRANIAL ARTERIOSCLEROSIS; LINEAR MODELS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; SENILE PLAQUES; SEX FACTORS;

EID: 66749123536     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000222779     Document Type: Article

References (24)

1. Parker GR, Cathcart HM, Huang R, Lanham IS, Corder EH, Poduslo SE: Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease. Psychiatr Genet 2005; 15: 271-275.
2. Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H: The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 2004; 1019 : 24-28.
3. Polvikoski T, Sulkava R, Myllykangas L, Notkola IL, Niinistö L, Verkkoniemi A, Kainulainen K, Kontula K, Pérez-Tur J, Hardy J, Haltia M: Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology 2001; 56: 1690 -1696.
4. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J: Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 20 06; 5: 735-741.
5. Snowdon DA: Aging and Alzheimer's disease: lessons from the nun study. Gerontologist 1997; 37: 150 -156.
6. Kalback W, Esh C, Castaño EM, Rahman A, Kokjohn T, Luehrs DC, Sue L, Cisneros R, Gerber F, Richardson C, Bohrmann B , Walker DG, Beach TG, Roher AE: Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res 2004; 26: 525-539.
7. Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbagh M, Walker DG, Roher AE: Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathologica (Berlin) 2007; 113:13-21.
8. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, Sue LI, Beach TG: Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 2003; 23:2055-2062.
9. Roher AE, Esh C, Rahman A, Kokjohn TA, Beach TG: Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 2004; 35: 2623-2627.
10. Roher AE, Kokjohn TA, Beach TG: An association with great implications: vascular pathology and Alzheimer disease. Alzheimer Dis Assoc Disord 2006; 20:73-75.
11. de la Torre JC: Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion? Ann Neurol 2005; 57: 783 -784 .
12. de la Torre JC: Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3: 18 4 -19 0 .
13. Iadecola C, Gorelick PB: Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke 2003; 34: 335- 337.
14. Iadecola C: Atherosclerosis and neurodegeneration: unexpected conspirators in Alz heimer's dementia. Arterioscler Thromb Vasc Biol 2003; 23:1951-1953.
15. Honig LS, Kukull W, Mayeux R: Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurolog y 2005; 64: 494-500.
16. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM: Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 2005; 57: 789-794.
17. Aho L, Jolkkonen J, Alafuzoff I: Beta-amyloid aggregation in human brains with cerebrovascular lesions. Stroke 20 06; 37: 2940 - 2945.
18. Alafuzoff I, Helisalmi S, Mannermaa A, Soininen H: Severity of cardiovascular disease, apolipoprotein E genotype, and brain pathology in aging and dementia. Ann N Y Acad Sci 2000; 903: 244-251.
19. Alafuzoff I, Helisalmi S, Mannermaa A, Riekkinen P, Soininen H: Beta-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients. Stroke 1999; 30: 613 - 618 .
20. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuro-pathologic assessment of Alzheimer's disease. Neurology 1991; 41:479-486.
21. Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol 1985; 42:1097-1105.
22. Braak H, Braak E: Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995; 16:271-278; discussion 278-284.
23. Harding AJ, Kril JJ, Halliday GM: Practical measures to simplify the Braak tangle staging method for routine pathological screening. Acta Neuropathol (Berlin) 2000; 99:199 - 208.
24. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31:545 - 548.